Papers/PMID:29256406
Magnesium supplementation affects gene expression related to insulin and lipid in patients with gestational diabetes.
Magnesium research2017The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
magnesium(2+) — decreases fasting blood glucose
Evidence strength: very limited.Findingreplicated ×11“Compared with the placebo, magnesium supplementation to women with GDM resulted in a significant decrease in levels of fasting plasma glucose (FPG) (-9.7 ± 5.6 vs. -0.1 ± 8.5 mg/dL, P<0.001).”
Quoted verbatim from Magnesium supplementation affects gene expression related to insulin and lipid in patients with gestational diabetes.. - Study
- RCT
- Duration
- 6 weeks
- Dose
- 250 mg/day magnesium oxide for 6 weeks
- Population
- Women aged 18-40 with gestational diabetes not on oral hypoglycemic agents
Magnesium supplementation affects gene expression related to insulin and lipid in patients with gestational diabetes.2017PMID:2925640610.1684/mrh.2017.0425Permalink